BlackRock Fund Advisors’s Bristol-Myers Squibb BMY Stock Holding History

BlackRock Fund Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.46B	Buy	25,035,963 +674,977	+3%	+$36.9M	0.27%	50
2016 Q3	$1.31B	Buy	24,360,986 +580,043	+2%	+$37.3M	0.27%	52
2016 Q2	$1.75B	Buy	23,780,943 +659,425	+3%	+$46.6M	0.39%	38
2016 Q1	$1.48B	Sell	23,121,518 -1,650,018	-7%	-$104M	0.34%	43
2015 Q4	$1.7B	Buy	24,771,536 +1,043,121	+4%	+$68.9M	0.39%	38
2015 Q3	$1.4B	Buy	23,728,415 +104,082	+0.4%	+$6.6M	0.36%	40
2015 Q2	$1.57B	Buy	23,624,333 +609,460	+3%	+$40.2M	0.38%	37
2015 Q1	$1.48B	Buy	23,014,873 +283,887	+1%	+$17.8M	0.35%	39
2014 Q4	$1.34B	Buy	22,730,986 +898,610	+4%	+$50.7M	0.33%	42
2014 Q3	$1.12B	Buy	21,832,376 +660,099	+3%	+$33M	0.32%	42
2014 Q2	$1.03B	Buy	21,172,277 +268	+0%	+$13.2K	0.29%	44
2014 Q1	$1.1B	Sell	21,172,009 -553,538	-3%	-$29.5M	0.33%	39
2013 Q4	$1.15B	Sell	21,725,547 -169,900	-0.8%	-$8.65M	0.35%	36
2013 Q3	$1.01B	Buy	21,895,447 +85,790	+0.4%	+$3.77M	0.34%	35
2013 Q2	$975M	Buy	+21,809,657	New	+$947M	0.36%	33

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Fund Advisors's BMY Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Bristol-Myers Squibb (BMY) stake by 2.8% in Q4 2016, buying an estimated $36.9M and bringing the position to 25,035,963 shares worth $1.46B. The position accounts for 0.27% of the portfolio, ranked #50.

BlackRock Fund Advisors first reported a position in BMY in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.75B in Q2 2016. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

BlackRock Fund Advisors held 25,035,963 shares of Bristol-Myers Squibb worth $1.46B as of Q4 2016.
BlackRock Fund Advisors bought 674,977 Bristol-Myers Squibb shares in Q4 2016, an estimated $36.9M.
Bristol-Myers Squibb made up 0.27% of BlackRock Fund Advisors's portfolio in Q4 2016, its #50 holding.
BlackRock Fund Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's Bristol-Myers Squibb position peaked at $1.75B in Q2 2016.
1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.